These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25134152)

  • 1. Merger with AstraZeneca will create a scientific "powerhouse," says Pfizer.
    O'Dowd A
    BMJ; 2014 May; 348():g3341. PubMed ID: 25134152
    [No Abstract]   [Full Text] [Related]  

  • 2. UK industry consolidation is slow despite big merger.
    Mitchell P
    Nat Biotechnol; 2003 Mar; 21(3):215. PubMed ID: 12610553
    [No Abstract]   [Full Text] [Related]  

  • 3. Where will new drugs come from?
    Lancet; 2011 Jan; 377(9760):97. PubMed ID: 21215869
    [No Abstract]   [Full Text] [Related]  

  • 4. What should be done to improve the productivity of neurological research?
    Moses H; Martin JB
    Ann Neurol; 2006 Dec; 60(6):647-51. PubMed ID: 17192925
    [No Abstract]   [Full Text] [Related]  

  • 5. What's fueling the biotech engine?
    Aggarwal S
    Nat Biotechnol; 2007 Oct; 25(10):1097-104. PubMed ID: 17921989
    [No Abstract]   [Full Text] [Related]  

  • 6. Two Providences seek merger. Deal would create Pacific Northwest powerhouse.
    Benko LB
    Mod Healthc; 2005 Oct; 35(42):20. PubMed ID: 16274188
    [No Abstract]   [Full Text] [Related]  

  • 7. Putting pressure on Tenet.
    Serwer A
    Fortune; 2003 Sep; 148(4):173-4. PubMed ID: 12964299
    [No Abstract]   [Full Text] [Related]  

  • 8. Will we like tomorrow's giants?
    Scott L
    Mod Healthc; 1996 Aug; 26(32):79-80, 84-6, 88. PubMed ID: 10158987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. UK bidding war amidst merger mania.
    Mitchell P
    Nat Biotechnol; 2003 Apr; 21(4):343-4. PubMed ID: 12665805
    [No Abstract]   [Full Text] [Related]  

  • 10. 'To make a difference'.
    Blye CM
    Healthc Financ Manage; 2006 Feb; 60(2):52-5. PubMed ID: 16519211
    [No Abstract]   [Full Text] [Related]  

  • 11. Juggling act. The challenges of managing multiple sites.
    Davis SG
    Health Facil Manage; 2004 Jun; 17(6):14-8. PubMed ID: 15227924
    [No Abstract]   [Full Text] [Related]  

  • 12. Defining innovation.
    Hughes B
    Nat Rev Drug Discov; 2009 Sep; 8(9):683-4. PubMed ID: 19721435
    [No Abstract]   [Full Text] [Related]  

  • 13. David Haslam. Interview by Asher Mullard.
    Haslam D
    Nat Rev Drug Discov; 2013 Jul; 12(7):500. PubMed ID: 23764976
    [No Abstract]   [Full Text] [Related]  

  • 14. [Not Available].
    Kiefer B
    Rev Med Suisse; 2016 Apr; 12(515):816. PubMed ID: 27276733
    [No Abstract]   [Full Text] [Related]  

  • 15. Hospital cost efficiency.
    Rosko MD
    Inquiry; 2003; 40(3):310-1. PubMed ID: 14680262
    [No Abstract]   [Full Text] [Related]  

  • 16. Gaining medical momentum.
    Blake D
    Nature; 2004 Jun; 429(6991 Suppl):19-23. PubMed ID: 15175707
    [No Abstract]   [Full Text] [Related]  

  • 17. The NIH, research institutions and industry: working together on a shared goal.
    Omary MB
    Gastroenterology; 2007 May; 132(5):1647-50. PubMed ID: 17484859
    [No Abstract]   [Full Text] [Related]  

  • 18. Mining revenue cycle opportunities in health-system-based medical practices.
    Lewins G; Chapdelaine JM
    Healthc Financ Manage; 2007 Sep; 61(9):104-8, 110, 112 passim. PubMed ID: 17937126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. US drug firm Pfizer seeks to buy UK company AstraZeneca.
    Jack A
    BMJ; 2014 Apr; 348():g2986. PubMed ID: 24778296
    [No Abstract]   [Full Text] [Related]  

  • 20. Sizing up systems. Catholic consolidations, such as Ascension Health, create industry giants and take on multiple religious sponsors.
    Bellandi D
    Mod Healthc; 1999 Nov; 29(44):38-40, 42. PubMed ID: 10623254
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.